{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-023933","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2025-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.242910+00:00","generated_at":"2026-05-16T19:20:12.122659+00:00","sec_items":["1.01","3.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"confidence":"high","headline":"Ensysce Biosciences closes $4M convertible preferred stock financing with up to $20M available","bullets":["Closed $4M convertible preferred stock financing; up to $16M additional available in future tranches over 24 months.","Conversion price fixed at $2.50/share; 50% warrant coverage exercisable at same price for five years.","Proceeds to accelerate Phase 3 clinical development of PF614, a novel abuse-resistant analgesic.","Series B preferred pays 4% annual dividend (8% on triggering events); stated value $1,100 per share.","Net proceeds from the offerings estimated at ~$3.6 million for general corporate purposes and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-023933","json":"https://secwatch.observer/filing/0001493152-25-023933.json","markdown":"https://secwatch.observer/filing/0001493152-25-023933.md","text":"https://secwatch.observer/filing/0001493152-25-023933.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/0001493152-25-023933-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:20:12.122659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}